Declining kidney function is strongly linked to dementia, according to a 10-year study of older adults. This has negative implications for Latinos, who are not only at a high risk for Alzheimer’s and related dementias, but also for chronic kidney disease (CKD). “The kidneys and the brain, both being end organs, are thought to be susceptible to vascular damage due to similar anatomic and hemodynamic features,” according to the researchers. Learn more about what the study found on the link between poor kidney function and dementia, why Latinos are disproportionately affected by these diseases, and how we can help further the research of Latino chronic disease through clinical trials.
What Did the Study Find on Kidney Function and Dementia?
Researchers from the University ...
A San Antonio woman in her 70s underwent South Texas’ first deep brain stimulation (DBS) surgery for Alzheimer’s — one of the first 300 surgeries of its kind in the world — at University Hospital on Nov. 5, 2021. UT Health San Antonio and clinical partner University Health are among 27 clinical trial sites worldwide evaluating the effectiveness of the DBS technique in a clinical trial to treat patients with mild Alzheimer’s disease. DBS is an established, nonpharmaceutical treatment that researchers hope could slow or even halt the progress of this devastating disease. Dr. Alexander Papanastassiou, associate professor of neurosurgery at UT Health San Antonio who sees University Health patients, implanted DBS electrodes during the operation. The surgery is minimally ...
Want to play memory and thinking tests and help millions of families with dementia? The Brain Health Registry can help you do that. Researchers at the University of California San Francisco (UCSF) developed a registry for adults interested in conducting brain tests that can help the future creation of treatments for Alzheimer’s, dementia, Parkinson’s, and other brain disorders. Now, they’re partnering with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio to expand brain health research in the Texas region of the United States, through a partnership called STOP-AD. Learn about the STOP-AD Brain Health Registry, how Alzheimer’s is affecting Latinos, and how clinical trials can help us tackle Alzheimer’s and other ...
Dr. Mirella Díaz-Santos has a personal fight to end Alzheimer’s Disease. Her grandmother was diagnosed with Alzheimer’s when Díaz-Santos was in school. “I needed to know more about how this ‘disease’ can change someone who you love so much. How can it change it completely?” Díaz-Santos said. Díaz-Santos is an assistant professor in residence at University of California at Los Angeles (UCLA) in the department of neurology and psychiatry. She’s also the director of research of the Hispanic Neuropsychiatric Center of Excellence at the Semel Institute for Neuroscience and Human Behavior and is involved with the Women’s Alzheimer’s Movement to bring awareness to Alzheimer’s within the Latino community. Although she’s experienced bias and discrimination ...
Did you know that every 65 seconds, someone develops Alzheimer’s disease? This number is most troubling for Latinos and women. Latinos overall are 1.5 times more likely to develop Alzheimer’s than their White peers. Two-thirds of Alzheimer’s patients are women. Latinas are at higher risk than non-Latinas. In response, the federal government created a website, Alzheimers.gov, for dementia information, resources, and clinical trials. Now that website is also in Spanish at Alzheimers.gov/es! Each website has: Information about Alzheimer’s disease and related dementias, including causes, symptoms, diagnosis, and treatment.
Knowledge and resources for caregivers and people living with dementia.
Clinical trials and studies that people can join to help advance ...
Día de los Muertos, also known as Day of the Dead, is a lively annual Mexican holiday that celebrates friends and family members who have passed away. Characterized by vibrant parades, singing, traditional dress and costumes, and altar building, Día de los Muertos brings unity between the living and returning spirits. “This indigenous holiday from Mexico celebrates the loving connection between the living and our departed loved ones that is so deeply missing in Western culture,” said Aya de Leon, a Puerto Rican novelist and Berkley professor, as reported by San Antonio Express News. For Día de los Muertos, our team at Salud America! is honored to remember the loved ones we’ve lost from COVID-19 and other conditions, and protect the health of our living familia.
1. ...
Are you Latino? Have you participated in a clinical trial related to cancer, Alzheimer’s, or another condition? If so, we want to talk with you and share your story! Salud America! is looking to interview and write stories about heroes like you — Latinos who have participated in a clinical trial — to showcase the benefits of volunteering to inspire other Latinos to volunteer, too. Dr. Amelie G. Ramirez’s Salud America! program at UT Health San Antonio is sharing the stories of clinical trial heroes with the support of Genentech, a member of the Roche Group. “Clinical trials are studies that help researchers learn more and more to help slow, manage, and treat Alzheimer's and cancer,” Ramirez said. “Clinical trials help us fight for our familia.” To share ...
Today, the National Institute on Aging (NIA) of the National Institutes of Health (NIH) designated UT Health San Antonio and UT Texas Rio Grande Valley as an Alzheimer’s Disease Research Center to boost research and reduce the Alzheimer's burden among Latinos, who suffer disparities in dementia. The new center is the first in South Texas. It joins 32 other centers nationwide that are accelerating research on effective Alzheimer’s and dementia prevention, diagnostics, and treatments, and improving support for families and caregivers. Salud America! is a center partner to promote its research and clinical trials. "This federal designation by NIA will be transformational as we seek cures and provide the best possible care, based on the most up-to-date knowledge and technology, ...
Sadly, Latinos are 1.5 times more likely to develop Alzheimer’s disease than whites. Across the board, Latinos are underrepresented in clinical research. Without Latino representation in Alzheimer's clinical trials, researchers cannot find treatments that work best for this population. Researchers also must understand and address the differential role of Alzheimer's among Latinos, and the impact of alcohol, sleep deprivation, diabetes, and more. Let’s use #SaludTues on Tuesday, Oct. 5, 2021, to tweet about the latest research and beneficial strategies and clinical trials to reduce Alzheimer's disease and promote better brain health among Latinos and all people! WHAT: #SaludTues: Importance of Latino Participation in Clinical Trials in Alzheimer’s Disease
TIME/DATE: ...
